✦ LIBER ✦

Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study

✍ Scribed by Minoru Takada; Shun-ichi Negoro; Shinzo Kudo; Kiyoyuki Furuse; Hideki Nishikawa; Yoshiki Takada; Tadashi Kamei; Hisanobu Niitani; Masahiro Fukuoka

Publisher: Springer
Year: 1997
Tongue: English
Weight: 177 KB
Volume: 41
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050731

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine and carbop

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

✍ Lin Run Wang; Ming Zhu Huang; Guo Bing Zhang; Nong Xu; Xiu Hua Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 385 KB

Gemcitabine, ifosfamide and paclitaxel i

Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study

✍ F. V. Piantedosi; F. Caputo; G. Mazzarella; M. Gilli; A. Pontillo; D. D’Agostino 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 206 KB

A phase II randomized trial of gemcitabi

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

Gemcitabine plus docetaxel as first-line

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

Randomized phase II study of carboplatin

Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer : West Japan Thoracic Oncology Group (WJTOG) 0104

✍ Nobuyuki Yamamoto; Kazuhiko Nakagawa; Hisao Uejima; Takahiko Sugiura; Yoshiki Ta 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Alternating weekly administration of pac

Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small-cell lung cancer

✍ David Aguiar; José Aguiar; Uriel Bohn 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB